FDA Grants Breakthrough Designation for Nyxoah Genio System for Obstructive Sleep Apnea & Complete Concentric Collapse

The FDA will provide the Genio system with priority review and interaction with FDA’s experts throughout the premarket review phase until the product is commercialized in the United States.

Leave a Reply